Literature DB >> 3877761

Cell surface glycoproteins involved in the stimulation of interleukin 1-dependent interleukin 2 production by a subline of EL4 thymoma cells. II. Structure, biosynthesis, and maturation.

B Lüscher, M Rousseaux, R Lees, H R MacDonald, C Bron.   

Abstract

In the present study, we examined the biosynthesis and the maturation of two distinct membrane glycoproteins detected by two monoclonal antibodies (RL388 and RL119), which were selected on the basis of their ability to stimulate the production of interleukin 2 by a subline of the murine EL4 thymoma. RL388 detected a disulfide-linked heterodimer complex (Mr = 130,000) composed of a glycosylated heavy (Mr = 86,000) and a nonglycosylated light (Mr = 39,000) subunit. The unglycosylated precursor of the heavy chain was a polypeptide of Mr = 57,500, which was converted upon maturation into a Mr = 73,000 core-glycosylated intermediate, and then into the Mr = 86,000 surface-expressed molecule. Partial endo-H digestion of the core-glycosylated form suggested the presence of four N-linked glycan units. The antibody reacted with a protein determinant expressed on the mature form as well as the unglycosylated precursor of the heavy chain. Moreover, both subunits assembled rapidly during biosynthesis, and the glycosylation of the heavy chain was not required for this association. Taken together, these data suggest that the antigen detected by RL388 may be the murine homologue of the human 4F2 antigen. The antigen identified by RL119 was a surface glycoprotein of Mr = 55,000 with three to five N-linked glycan units. The unglycosylated precursor polypeptide was of Mr = 29,000. The fully core-glycosylated form of Mr = 41,000, which was detected after inhibition of glucosidase I with 1-deoxynojirimycin, was converted into a Mr = 39,000 intermediate, and upon further trimming, into a Mr = 36,000 endo-H-sensitive form. The latter could be detected for chase periods of over several hours, thus suggesting a low rate of intracellular processing. The wide cellular distribution of the molecules identified by RL388 and RL119 and their preferential expression on the surface of growing cells suggests that they may be associated with cell activation events.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877761

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Controlling tumor-derived and vascular endothelial cell growth: role of the 4Ff2 cell surface antigen.

Authors:  M Papetti; I M Herman
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen).

Authors:  S Dong; R C Hughes
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

3.  Stimulation of system y(+)-like amino acid transport by the heavy chain of human 4F2 surface antigen in Xenopus laevis oocytes.

Authors:  J Bertran; S Magagnin; A Werner; D Markovich; J Biber; X Testar; A Zorzano; L C Kühn; M Palacin; H Murer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta.

Authors:  B Mosley; S K Dower; S Gillis; D Cosman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

5.  The Ly-10 antigen is a marker of mouse-activated T lymphocytes.

Authors:  M M Chan; U Hämmerling; O Stutman
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes.

Authors:  Shiho Ueda; Hidemi Hayashi; Takako Miyamoto; Shinya Abe; Kana Hirai; Kanji Matsukura; Hideki Yagi; Yuta Hara; Kinji Yoshida; Shogo Okazaki; Masakazu Tamura; Yuki Abe; Toshinori Agatsuma; Shin-Ichiro Niwa; Kazue Masuko; Takashi Masuko
Journal:  Cancer Sci       Date:  2019-01-04       Impact factor: 6.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.